The purpose of this study is to compare two different approaches to managing the bacteria in the urine before the botulinum toxin injection. One approach involves giving antibiotics around the time of the injection, which is the current standard practice, while the other approach avoids giving antibiotics unless symptoms develop later. The study aims to determine whether avoiding antibiotics initially is just as safe and effective as the standard approach in preventing urinary tract infections that cause symptoms after the injection. A urinary tract infection with symptoms would include signs such as fever, pain during urination, or other clear indicators that the infection is causing problems in the body.

During the study, patients will have their urine tested about five days before the scheduled botulinum toxin injection to check for bacteria. Following the injection, they will be monitored for six weeks to see if they develop a symptomatic urinary tract infection. The study will also track other health events, visits to emergency departments, and unplanned hospital admissions during this period. At the six-week mark, patients will undergo bladder function tests and keep a three-day diary recording how often they need to use catheterization, episodes of urgency, and any incontinence episodes. The study will measure various aspects of bladder function, including bladder capacity and pressure, to assess how well the botulinum toxin treatment is working.

The purpose of this study is to check if this combined treatment is safe and practical to use in people with chronic spinal cord injury. The study will carefully watch for any unwanted effects or complications that might occur during or after the treatment. It will also look at whether the treatment causes any worsening of movement, sensation, or body functions that are controlled automatically, such as blood pressure and temperature regulation. Additionally, the study will examine samples of the fluid around the spinal cord to see if the body develops any immune reactions to the stem cells.

During the study, participants will receive the stem cell infusions at specific times and will take part in the rehabilitation program with electrical stimulation. The study team will track whether participants are able to follow the treatment plan and complete all the required visits and procedures. They will also note any practical difficulties that come up when combining these two types of treatment. Throughout the entire process, doctors will monitor participants closely using physical examinations, measurements of vital signs like heart rate and blood pressure, and laboratory tests to ensure safety and gather information about how well this approach works in a real medical setting.

Participants in the study will receive the Baclofen treatment over a period of time, and their health will be closely monitored. The study will look at how the treatment affects their breathing and sleep, as well as how it impacts muscle stiffness, which is a common issue for people with spinal cord injuries. The study will also gather feedback from participants about their satisfaction with the treatment and how it affects their daily activities.

The study aims to provide valuable information about the safety and effectiveness of using Baclofen in this way, helping to improve treatment options for individuals with spinal cord injuries. Participants will be observed to ensure that their breathing remains within safe limits and that any necessary adjustments to their treatment are made to maintain their well-being.

The purpose of the study is to evaluate how safe and tolerable the new treatment is, as well as how effective it might be in improving the condition of patients with spinal cord injuries. Participants in the study will receive either the new treatment along with standard care or just the standard care alone. The study will monitor changes in the participants’ motor and sensory functions, which are important for movement and feeling, over a period of time.

Throughout the study, researchers will observe the participants to see if there are any side effects from the treatment and how the treatment affects their recovery. The study will also look at how long participants need to stay in the hospital and in intensive care. This information will help determine if the new treatment can offer benefits beyond the current standard care for people with spinal cord injuries.